Uxin (UXIN) COO details large direct and indirect option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Uxin Ltd Chief Operating Officer Zhang Zhitian reported existing holdings of employee share options linked to the company’s Class A ordinary shares. These positions reflect rights to buy shares rather than recent market trades.
Zhang holds options directly over 300,000 underlying shares at an exercise price of $1.0300 per share and over 210,000 underlying shares at $0.0330 per share, all expiring on August 20, 2028. In addition, 282,016,200 underlying shares are subject to options held indirectly through MENGMENG Limited, a British Virgin Islands company beneficially owned by Zhang through a trust, of which he is the sole director.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Zhang Zhitian
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee share options (right to buy) | -- | -- | -- |
| holding | Employee share options (right to buy) | -- | -- | -- |
| holding | Employee share options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Employee share options (right to buy) — 300,000 shares (Direct);
Employee share options (right to buy) — 282,016,200 shares (Indirect, By MENGMENG Limited)
Footnotes (1)
- [object Object]
FAQ
What insider holdings did Uxin (UXIN) COO Zhang Zhitian report?
Zhang reported existing employee share options over Uxin Class A shares. These include direct options on 510,000 underlying shares and additional indirect options on 282,016,200 underlying shares, providing rights to buy shares rather than documenting new market transactions.
What is the scale of Zhang Zhitian’s indirect Uxin (UXIN) option holdings?
Indirectly, options over 282,016,200 underlying Class A ordinary shares are held through MENGMENG Limited. The filing notes MENGMENG Limited is a British Virgin Islands company beneficially owned by Zhang via a trust, with Zhang serving as sole director.
What are the exercise prices and expiry dates of the reported Uxin options?
The options have exercise prices of $1.0300, $0.0330, and $0.0001 per share. All series of options reported in the filing share the same expiration date of August 20, 2028, defining the timeframe in which they can be exercised.